BMY•benzinga•
Bristol-Myers Squibb shares are trading higher after the company received FDA approval for Sotyktu for moderate-to-severe plaque psoriasis.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga